Complement and Fc function are required for optimal antibody prophylaxis against Pneumocystis carinii pneumonia

被引:25
作者
Wells, J
Haidaris, CG
Wright, TW
Gigliotti, F
机构
[1] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA
[2] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA
关键词
D O I
10.1128/IAI.74.1.390-393.2006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pneumocystis carinii is an opportunistic fungal pathogen that causes P. carinii pneumonia (PCP) in the immunocompromised host. We investigated the role of antibody Fe-mediated function in passive prophylaxis against the development of PCP in SCID mice. By comparison of anti-mouse P. carinii immunoglobulin G1 monoclonal antibody (MAb) 4F11(G1) and its F(ab')2 derivative in an intranasal immunoprophylaxis model, we determined that Fc-mediated function is required for maximum effect of this antibody. Comparison of efficacy of antibody prophylaxis in SCID mice depleted of complement to that in nondepleted mice demonstrated that complement fixation by MAb 4F11(G1) is also necessary for optimal effect of passively administered antibody, although residual protection was observed in complement-depleted SCID mice. The necessity of complement for optimal PCP prophylaxis by MAb 4F11(G1) suggests that complement may play a role in antibody-mediated protection against development of PCP.
引用
收藏
页码:390 / 393
页数:4
相关论文
共 30 条
[1]   PASSIVE IMMUNOPROPHYLAXIS WITH SPECIFIC MONOCLONAL-ANTIBODY CONFERS PARTIAL PROTECTION AGAINST PNEUMOCYSTIS-CARINII PNEUMONITIS IN ANIMAL-MODELS [J].
GIGLIOTTI, F ;
HUGHES, WT .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (06) :1666-1668
[2]   Characterization of transmission of Pneumocystis carinii f. sp muris through immunocompetent BALB/c mice [J].
Gigliotti, F ;
Harmsen, AG ;
Wright, TW .
INFECTION AND IMMUNITY, 2003, 71 (07) :3852-3856
[3]   Passive intranasal monoclonal antibody prophylaxis against murine Pneumocystis carinii pneumonia [J].
Gigliotti, F ;
Haidaris, CG ;
Wright, TW ;
Harmsen, AG .
INFECTION AND IMMUNITY, 2002, 70 (03) :1069-1074
[4]   Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies [J].
Han, Y ;
Kanbe, T ;
Cherniak, R ;
Cutler, JE .
INFECTION AND IMMUNITY, 1997, 65 (10) :4100-4107
[5]   ANTIBODY-RESPONSE THAT PROTECTS AGAINST DISSEMINATED CANDIDIASIS [J].
HAN, YM ;
CUTLER, JE .
INFECTION AND IMMUNITY, 1995, 63 (07) :2714-2719
[6]   Complement is essential for protection by an IgM and an IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasis [J].
Han, YM ;
Kozel, TR ;
Zhang, MX ;
MacGill, RS ;
Carroll, MC ;
Cutler, JE .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1550-1557
[7]   REQUIREMENT FOR CD4+ CELLS IN RESISTANCE TO PNEUMOCYSTIS-CARINII PNEUMONIA IN MICE [J].
HARMSEN, AG ;
STANKIEWICZ, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (03) :937-945
[8]  
HIDALGO HA, 1992, INFECT IMMUN, V60, P1
[9]   New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia [J].
Kovacs, JA ;
Gill, VJ ;
Meshnick, S ;
Masur, H .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (19) :2450-2460
[10]  
LAURSEN AL, 1994, CLIN EXP IMMUNOL, V98, P196, DOI 10.1111/j.1365-2249.1994.tb06125.x